MARKET WIRE NEWS
  1. Home
  2. Stock
  3. CCCC
  4. News
CCCC
Quote
Short
News
Articles
Message Board

C4 Therapeutics Inc. (NASDAQ : CCCC ) News

News Releases

CCCC News Releases
CCCC : NASDAQ
SeekingAlpha
C4 Therapeutics, Inc. (CCCC) Discusses Evolving Multiple Myeloma Treatments and the Role of IKZF1/3 Degraders Including Cemsidomide Transcript
CCCC : NASDAQ
SeekingAlpha
Monte Rosa: Initiating Coverage With A Buy On Degrader Platform Potential
CCCC : NASDAQ
GlobeNewswire
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population
CCCC : NASDAQ
SeekingAlpha
C4 Therapeutics "Buy" On Cemsidomide Advancement And Competitor's Positive Readout
CCCC : NASDAQ
SeekingAlpha
Bristol-Myers multiple myeloma data boosts C4
CCCC : NASDAQ
GlobeNewswire
C4 Therapeutics to Participate in Upcoming Conferences
CCCC : NASDAQ
SeekingAlpha
C4 Therapeutics GAAP EPS of -$0.20 beats by $0.06, revenue of $6.15M beats by $1.73M
CCCC : NASDAQ
GlobeNewswire
C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
CCCC : NASDAQ
KlickAnalytics
CCCC - Historical Price Movements Surrounding Earnings
CCCC : NASDAQ
KlickAnalytics
CCCC - Historical Earnings Price Analysis
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.